invalid group:NA
Sponsors
The First Affiliated Hospital of Zhengzhou University, Beijing Hospital
Conditions
Primary IgA Nephropathyhepatocellular carcinoma
Unknown Phase
Exosomal markers for prognostic prediction of TACE combined with molecularly targeted drugs in the treatment of intermediate and advanced hepatocellular carcinoma
RecruitingChiCTR2400082483
Start: 2023-10-05Updated: 2024-04-01
Clinical Studies on the Efficacy of IgA Nephropathy Treatment
Active, not recruitingChiCTR2600117421
Start: 2025-08-07Updated: 2026-01-27